Profound Medical (TSE:PRN) Reaches New 12-Month Low – Should You Sell?

Profound Medical Corp. (TSE:PRN) hit a new 52-week low during trading on Friday . The stock traded as low as C$7.00 and last traded at C$6.93, with a volume of 1828 shares. The stock had previously closed at C$7.55.

Profound Medical Price Performance

The business’s fifty day moving average price is C$9.50 and its 200 day moving average price is C$10.27. The company has a debt-to-equity ratio of 20.05, a current ratio of 6.12 and a quick ratio of 14.98. The stock has a market cap of C$17.34 million, a P/E ratio of -3.66 and a beta of 1.17.

Insider Activity at Profound Medical

In other news, Director Arun Menawat Dr. acquired 14,200 shares of Profound Medical stock in a transaction that occurred on Friday, March 14th. The shares were acquired at an average price of C$10.09 per share, for a total transaction of C$143,319.75. 8.62% of the stock is owned by insiders.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.